Chief Executive Officer
Chairman of the Board
Harlan Weisman served over 20 years as a senior executive at Johnson & Johnson including Chief Science and Technology Officer of the J&J Medical Devices and Diagnostics Group and Company Group Chairman, Research & Development for Pharmaceuticals, where he had executive oversight of the ALZA Corporation, J&J Pharmaceutical Research and Development, and TransForm Pharmaceuticals. Dr. Weisman joined J&J from Centocor, where he was the President of Research & Development. He also served as CEO of Coronado Biosciences and was previously an Assistant Professor of Medicine at Johns Hopkins University School of Medicine.
Dr. Weisman received a B.A. from the University of Maryland and his M.D. from the University of Maryland School of Medicine. He did his residency in Internal Medicine at Mount Sinai Hospital in New York and a post-graduate fellowship in cardiovascular disease at Johns Hopkins Medical Institutions.